These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 38396330)
21. Nanoparticle-based drug delivery systems for controllable photodynamic cancer therapy. Zheng Y; Li Z; Chen H; Gao Y Eur J Pharm Sci; 2020 Mar; 144():105213. PubMed ID: 31926941 [TBL] [Abstract][Full Text] [Related]
22. Mitochondria Targeted O Yuan P; Deng FA; Liu YB; Zheng RR; Rao XN; Qiu XZ; Zhang DW; Yu XY; Cheng H; Li SY Adv Healthc Mater; 2021 Jun; 10(12):e2100198. PubMed ID: 33938637 [TBL] [Abstract][Full Text] [Related]
23. Upconversion nanoparticle-based optogenetic nanosystem for photodynamic therapy and cascade gene therapy. Song X; Li F; Tian F; Ren L; Wang Q; Jiang C; Yan T; Zhang S Acta Biomater; 2023 Feb; 157():538-550. PubMed ID: 36494007 [TBL] [Abstract][Full Text] [Related]
24. Mitochondria-Targeting Upconversion Nanoparticles@MOF for Multiple-Enhanced Photodynamic Therapy in Hypoxic Tumor. Chen Y; Yang Y; Du S; Ren J; Jiang H; Zhang L; Zhu J ACS Appl Mater Interfaces; 2023 Aug; 15(30):35884-35894. PubMed ID: 37487181 [TBL] [Abstract][Full Text] [Related]
25. Light-responsive smart nanocarriers for wirelessly controlled photodynamic therapy for prostate cancers. Sun B; Liu J; Kim HJ; Rahmat JNB; Neoh KG; Zhang Y Acta Biomater; 2023 Nov; 171():553-564. PubMed ID: 37739246 [TBL] [Abstract][Full Text] [Related]
26. A Review of Light Sources and Enhanced Targeting for Photodynamic Therapy. Xiang M; Zhou Q; Shi Z; Wang X; Li M; Jia Y; Li S; Yang F; Wang W; Chen T; Xu X; Sharma B; Nie Y; Xiao Q; Gao L Curr Med Chem; 2021; 28(31):6437-6457. PubMed ID: 33475053 [TBL] [Abstract][Full Text] [Related]
27. Recent advances in type I organic photosensitizers for efficient photodynamic therapy for overcoming tumor hypoxia. Lu B; Wang L; Tang H; Cao D J Mater Chem B; 2023 May; 11(21):4600-4618. PubMed ID: 37183673 [TBL] [Abstract][Full Text] [Related]
28. Targeting immunogenic cancer cell death by photodynamic therapy: past, present and future. Alzeibak R; Mishchenko TA; Shilyagina NY; Balalaeva IV; Vedunova MV; Krysko DV J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33431631 [TBL] [Abstract][Full Text] [Related]
30. Expanding the Limits of Photodynamic Therapy: The Design of Organelles and Hypoxia-Targeting Nanomaterials for Enhanced Photokilling of Cancer. Calori IR; Bi H; Tedesco AC ACS Appl Bio Mater; 2021 Jan; 4(1):195-228. PubMed ID: 35014281 [TBL] [Abstract][Full Text] [Related]
31. Mitochondria and plasma membrane dual-targeted chimeric peptide for single-agent synergistic photodynamic therapy. Cheng H; Zheng RR; Fan GL; Fan JH; Zhao LP; Jiang XY; Yang B; Yu XY; Li SY; Zhang XZ Biomaterials; 2019 Jan; 188():1-11. PubMed ID: 30312907 [TBL] [Abstract][Full Text] [Related]
32. Photodynamic therapy of pancreatic cancer: Where have we come from and where are we going? Wang Y; Wang H; Zhou L; Lu J; Jiang B; Liu C; Guo J Photodiagnosis Photodyn Ther; 2020 Sep; 31():101876. PubMed ID: 32534246 [TBL] [Abstract][Full Text] [Related]
33. Light-triggered photodynamic nanomedicines for overcoming localized therapeutic efficacy in cancer treatment. Choi J; Sun IC; Sook Hwang H; Yeol Yoon H; Kim K Adv Drug Deliv Rev; 2022 Jul; 186():114344. PubMed ID: 35580813 [TBL] [Abstract][Full Text] [Related]
34. Photodynamic therapy of prostate cancer using porphyrinic formulations. Mesquita MQ; Ferreira AR; Neves MDGPMS; Ribeiro D; Fardilha M; Faustino MAF J Photochem Photobiol B; 2021 Oct; 223():112301. PubMed ID: 34492530 [TBL] [Abstract][Full Text] [Related]
35. Smart Nanoreactors for pH-Responsive Tumor Homing, Mitochondria-Targeting, and Enhanced Photodynamic-Immunotherapy of Cancer. Yang G; Xu L; Xu J; Zhang R; Song G; Chao Y; Feng L; Han F; Dong Z; Li B; Liu Z Nano Lett; 2018 Apr; 18(4):2475-2484. PubMed ID: 29565139 [TBL] [Abstract][Full Text] [Related]
36. In-situ bio-assembled specific Au NCs-Aptamer-Pyro conjugates nanoprobe for tumor imaging and mitochondria-targeted photodynamic therapy. Xiong H; Ye J; Wang M; Wang Y; Liu X; Jiang H; Wang X Biosens Bioelectron; 2022 Dec; 218():114763. PubMed ID: 36240628 [TBL] [Abstract][Full Text] [Related]
37. A pH-Activatable nanoparticle for dual-stage precisely mitochondria-targeted photodynamic anticancer therapy. Qi T; Chen B; Wang Z; Du H; Liu D; Yin Q; Liu B; Zhang Q; Wang Y Biomaterials; 2019 Aug; 213():119219. PubMed ID: 31132647 [TBL] [Abstract][Full Text] [Related]
38. Lysosomal cathepsin initiates apoptosis, which is regulated by photodamage to Bcl-2 at mitochondria in photodynamic therapy using a novel photosensitizer, ATX-s10 (Na). Ichinose S; Usuda J; Hirata T; Inoue T; Ohtani K; Maehara S; Kubota M; Imai K; Tsunoda Y; Kuroiwa Y; Yamada K; Tsutsui H; Furukawa K; Okunaka T; Oleinick NL; Kato H Int J Oncol; 2006 Aug; 29(2):349-55. PubMed ID: 16820876 [TBL] [Abstract][Full Text] [Related]
39. Photosensitizers for Photodynamic Therapy. Lan M; Zhao S; Liu W; Lee CS; Zhang W; Wang P Adv Healthc Mater; 2019 Jul; 8(13):e1900132. PubMed ID: 31067008 [TBL] [Abstract][Full Text] [Related]
40. Targeting mitochondria in cancer therapy: Insight into photodynamic and photothermal therapies. Kadkhoda J; Tarighatnia A; Nader ND; Aghanejad A Life Sci; 2022 Oct; 307():120898. PubMed ID: 35987340 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]